Keywords: astrazeneca, abbott, laboratories, develop, combination, cholesterol, drug

AstraZeneca and Abbott Laboratories to develop combination cholesterol drug

Article | 17 July 2006

Print This

Anglo-Swedish drug major AstraZeneca and US health care major Abbott Laboratories say they will collaborate on the development of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in